Short Interest in Autonomix Medical, Inc. (NASDAQ:AMIX) Drops By 58.7%

Autonomix Medical, Inc. (NASDAQ:AMIX) was the recipient of a significant decrease in short interest in August. As of August 14th, there was short interest totaling 108,801 shares, a decrease of 58.7% from the July 30th total of 263,441 shares. Currently, 11.9% of the shares of the company are short sold. Based on an average daily volume of 13,826,443 shares, the days-to-cover ratio is currently 0.0 days.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. Wall Street Zen lowered shares of Autonomix Medical to a “strong sell” rating in a research note on Saturday. Zacks Research upgraded Autonomix Medical to a “hold” rating in a research note on Tuesday, June 2nd. Finally, Weiss Ratings raised Autonomix Medical from a “sell (e)” rating to a “sell (e+)” rating in a research note on Tuesday, July 28th. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $42.00.

Autonomix Medical Stock Down 5.5%

Autonomix Medical stock traded down $0.31 during midday trading on Friday, reaching $5.32. 311,995 shares of the stock traded hands, compared to its average volume of 9,370,103. The stock’s fifty day moving average is $6.34 and its 200-day moving average is $7.56. Autonomix Medical has a 12 month low of $2.44 and a 12 month high of $32.55. The stock has a market cap of $5.17 million, a P/E ratio of -0.13 and a beta of -1.17.

Autonomix Medical (NASDAQ:AMIX) last released its quarterly earnings data on Wednesday, August 12th. The company reported ($5.02) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($6.40) by $1.38. On average, equities analysts predict that Autonomix Medical will post -20.17 EPS for the current fiscal year.

About Autonomix Medical

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.